San Diego biotech news from San Diego Union Tribune, PR Newswire, Businesswire and other sources, click on headlines to read the full story and see what’s trending.

San Diego biotech news from San Diego Union Tribune, PR Newswire, Businesswire and other sources, click on headlines to read the full story and see what’s trending.
SAN DIEGO–(BUSINESS WIRE)–Cytonus Therapeutics Inc. announced today that it has developed Cargocytes? a first-of-its-kind, controllable, cell-based platform technology for delivery of biologics. Cargocytes are engineered allogenic cell lines that can… […]
SAN DIEGO–(BUSINESS WIRE)–Cidara Therapeutics, Inc. (Nasdaq: CDTX), a biotechnology company developing novel anti-infectives including immunotherapies, today announced that data from studies of its lead antifungal rezafungin will be presented at the … […]
Battery-technology business Maxwell Technologies has agreed to be acquired by Silicon Valley electric car company Tesla (NASDAQ: TSLA) in an all-stock deal valued at about $218 million, the San Diego-based company announced Monday. Maxwell (NASDAQ: MXW… […]
San Diego’s Halozyme Therapeutics will get $30 million upfront, with the possibility of hundreds of millions more, under a licensing agreement with a European biotechnology company announced Monday. Argenx, based in the Netherlands, is licensing Ha… […]
SAN DIEGO–(BUSINESS WIRE)–Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) announces closing an investment in Dianomi Therapeutics, Inc., a biopharmaceutical company focused on improving the delivery and efficacy of large and small molecules in the… […]
It?s not too late to submit your nominations for the first-ever Xconomy Awards San Diego. We are extending the deadline for nominations to 5 p.m. PST on Thursday, Feb. 7. This week is your last chance to nominate in categories including Digital Trailbl… […]
Magnolia Medical Technologies, a Seattle-based manufacturer of devices for collecting blood and bodily fluids, announced this week it has raised $20 million in equity funding to ramp up sales of its flagship product. The funding comes as Magnolia and S… […]
Richard Pascoe
? Having handed off troubled microcap biotech Apricus Biosciences to Seelos Therapeutics via a merger, Richard Pascoe is moving on to his next CEO (and chairman) gig at Histogen. The regenerative medicine developer is anticipating data f… […]
A cancer-fighting gene known as the ?guardian of the genome? actually promotes certain tumors, according to a study by UC San Diego researchers. That means drugs that affect its activity may backfire in some cases, fueling the tumor?s growth. Calle… […]
Gossamer Bio is dropping its plan to pursue a little-used path to the public markets and will instead return to a conventional IPO that is reviewed by securities regulators. The company initially filed for an IPO as activity at the SEC ground to a halt… […]
Taylor Cavanah, whose background is in physics, once caused a fellow scientist to do a spit take after learning Cavanah runs a software startup focused on pet care. Just as surprising is the tale of how Cavanah and co-founders Ken Tsui and Aaron Bannis… […]
LYMINGTON, United Kingdom–(BUSINESS WIRE)–lt;a href="https://twitter.com/hashtag/2019ICPCPlenary?src=hash" target="_blank"gt;#2019ICPCPlenarylt;/agt;–The International Cable Protection Committee welcomes your participation at its… […]
All Gossamer Bio wants is to go public and fast, but the start and end of the US government shutdown has thrown its IPO plans into disarray, prompting the San Diego-based biotech to once again shift gear.
Sheila Gujrathi
In its hurry, the company has m… […]
Reports + Research UCSD Researchers Explore Another Way to Treat Alzheimer?s Disease A pathological hallmark of Alzheimer?s disease is the accumulation of amyloid beta plaques and tangles of tau proteins. A majority of the therapeutic development for A… […]
SAN DIEGO–(BUSINESS WIRE)–lt;a href="https://twitter.com/hashtag/OSA?src=hash" target="_blank"gt;#OSAlt;/agt;–OFC 2019 returns to San Diego, California to set the stage as the single-most important annual event in optical communi… […]
Translational Psychiatry, researchers at University of California San Diego School of Medicine describe how, in a novel mouse model, epigenetic regulation negatively impacts a downstream gene specifically involve… […]
Translational Psychiatry, researchers at University of California San Diego School of Medicine describe how, in a novel mouse model, epigenetic regulation negatively impacts a downstream gene specifically involve… […]
Translational Psychiatry, researchers at University of California San Diego School of Medicine describe how, in a novel mouse model, epigenetic regulation negatively impacts a downstream gene specifically involve… […]
SAN DIEGO–(BUSINESS WIRE)–Illumina, Inc. (NASDAQ: ILMN) today announced its financial results for the fourth quarter and fiscal year 2018. Fourth quarter 2018 results: Revenue of $867 million, an 11% increase compared to $778 million in the fourth qu… […]
It?s no surprise that muscles are important to our metabolism: it?s why building muscle at the gym can accelerate weight loss.?
Scientists are particularly interested in how muscle metabolism affects the heart, arguably the most important muscle in th… […]
The road to potential approval for Voyager Therapeutics? experimental gene therapy for Parkinson?s disease got a bit longer, and more expensive, last year. So this morning the company cut a deal with Neurocrine Biosciences to bankroll the journey?and f… […]
Abide Therapeutics, which is developing medicines to treat neurological diseases, has appointed Kevin Finney as its president and chief operating officer, a new role for the company. The company, which has about 40 employees, is co-located in San Diego… […]
A record year of venture investing has floated UK?s biotech boat, with the money flow in 2018 gushing over the ?1 billion mark for the first time.
A total of ?1.1 billion was raised thanks to a boom in late-stage financings, according to the latest rep… […]
In the 10th approval since its 2013 launch, J&J?s cancer drug Imbruvica has secured the FDA nod in combination with Roche?s?obinutuzumab in adults with the most common form of leukemia?? marking the first non-chemotherapy regimen for treatment-na?v… […]
financial windpipe for growing companies ? the ability to raise money through stock offerings ? is increasingly constricted by the partial government shutdown, industry experts say. Source: Public stock offerings hit by partial government shutdown […]
Copyright © 2023 Biotech Networks, LLC